These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 12843932
21. [Immunosuppressive agents in Dermatology]. Bressan AL, Silva RS, Fontenelle E, Gripp AC. An Bras Dermatol; 2010; 85(1):9-22. PubMed ID: 20464082 [Abstract] [Full Text] [Related]
22. Drug choices in autoimmune hepatitis: part B--Nonsteroids. Czaja AJ. Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712 [Abstract] [Full Text] [Related]
23. Evolving treatment strategies for inflammatory bowel disease. Hanauer SB, Dassopoulos T. Annu Rev Med; 2001 Sep; 52():299-318. PubMed ID: 11160781 [Abstract] [Full Text] [Related]
25. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis. Brunt EM, Di Bisceglie AM. Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334 [Abstract] [Full Text] [Related]
27. Iatrogenic immunodeficiency-associated lymphoproliferative disease of the Hodgkin lymphoma-like variant in a patient treated with mycophenolate mofetil for autoimmune hepatitis. Adams B, Lazarchick J, Medina AM, Willner IR, Neville B, Murphy E, Stuart R, Costa LJ. Am J Hematol; 2010 Aug 03; 85(8):627-9. PubMed ID: 20658594 [No Abstract] [Full Text] [Related]
28. Treating immunobullous diseases: an update. Reynaert S, Black MM. Dermatol Nurs; 2004 Feb 03; 16(1):29-34, 70. PubMed ID: 15022502 [Abstract] [Full Text] [Related]
29. Reply to: Comments on "An open-label randomised-controlled trial of azathioprine vs. mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis". Snijders RJALM, Stoelinga AEC, van Hoek B, Drenth JPH. J Hepatol; 2024 Jul 03; 81(1):e43-e44. PubMed ID: 38554845 [No Abstract] [Full Text] [Related]
36. Mycophenolate mofetil as a rescue therapy for autoimmune hepatitis patients who are not responsive to standard therapy. Fallatah HI, Akbar HO. Expert Rev Gastroenterol Hepatol; 2011 Aug 03; 5(4):517-22. PubMed ID: 21780898 [Abstract] [Full Text] [Related]
38. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study. Blumenstein I, Herrmann E, Filmann N, Zosel C, Tacke W, Bock H, Dignass A, Hartmann F, Zeuzem S, Stein J, Schröder O. J Crohns Colitis; 2011 Jun 03; 5(3):203-10. PubMed ID: 21575882 [Abstract] [Full Text] [Related]
39. American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association. Gastroenterology; 2006 Mar 03; 130(3):940-87. PubMed ID: 16530532 [No Abstract] [Full Text] [Related]
40. What is the calcineurin inhibitor of choice for pediatric renal transplantation? Kari JA, Trompeter RS. Pediatr Transplant; 2004 Oct 03; 8(5):437-44. PubMed ID: 15367278 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]